Log In
BCIQ
Print this Print this
 

Procomvax

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionVaccine comprised of Haemophilus influenzae type B capsular polysaccharide conjugated with the outer membrane protein of Neisseria meningitidis and recombinant hepatitis B surface antigen (HBsAg)
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today